Improved yield of minimal proportional sample volume platelet bacterial culture

Transfusion

Volumn 57, Issue 10, 2017, Pages 2413-2419

  Kamel, Hany ^a   Townsend, Mary ^a   Bravo, Marjorie ^a   Vassallo, Ralph R ^a  

^a Blood Systems Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABIOTROPHIA; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; APHERESIS; ARTICLE; BACILLUS; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD TRANSFUSION; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; ESCHERICHIA COLI; FALSE POSITIVE RESULT; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MICROCOCCUS; MIDDLE AGED; MORAXELLA; MORGANELLA MORGANII; NONHUMAN; SENSITIVITY ANALYSIS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; THROMBOCYTE VOLUME; BLOOD CULTURE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; QUALITY CONTROL; SEPSIS; THROMBOCYTE; TRANSMISSION;

BACTERIOLOGICAL TECHNIQUES; BLOOD CULTURE; BLOOD PLATELETS; BLOOD TRANSFUSION; HUMANS; QUALITY CONTROL; SEPSIS;

EID: 85021380030     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14198     Document Type: Article

References (24)

1. Dumont LJ, Kleinman S, Murphy JR, et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-99.
2. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2015 [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2015 [cited 2017 Mar 19]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM518148.pdf.
3. Greco-Stewart VS, Brown EE, Parr C, et al. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang 2012;102:212-;20.
4. Brecher ME, Blajchman MA, Yomtovian R, et al. Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future. Transfusion 2013;53:221-;31.
5. Snyder EL, Stramer SL, Richard J, et al. The safety of the blood supply—time to raise the bar. N Engl J Med 2015;372:1882-;4.
6. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Draft guidance for industry [Internet]. 2016 Mar [cited 2017 Mar 17]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM425952.pdf.
7. Kleinman S, Kamel H, Harpool D, et al. Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion 2006;46:1787-;94.
8. Su L, Kamel H, Custer B, et al. Bacterial detection in apheresis platelets: Blood Systems experience with a two-bottle and one-bottle culture system. Transfusion 2008;48:1842-;52.
9. Souza S, Bravo M, Poulin T, et al. Improving the performance of culture-based bacterial screening by increasing the sample volume from 4 mL to 8 mL in aerobic culture bottles. Transfusion 2012;52:1576-;82.
10. Bravo M, Shaz B, Kamel H, et al. Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor? Transfusion 2015;55:2113-;22.
11. Tomasulo P, Wagner S. Predicting improvement in detection of bacteria in apheresis platelets by maintaining constant component sampling proportion. Transfusion 2013;53:835-;42.
12. Brecher ME, Jacobs MR, Katz LM. Survey of methods used to detect bacterial contamination of platelet products in the United States in 2011. Transfusion 2013;53:911-;8.
13. Wagner SJ, Benjamin RJ, Hapip CA, et al. Investigation of bacterial inactivation in apheresis platelets with 24 or 30 hours between inoculation and inactivation. Vox Sang 2016;111:226-;34.
14. Jacobs M, Smith D, Heaton W, et al. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011;51:2573-;82.
15. Hong H, Xiao W, Lazarus H, et al. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood 2016;127:496-;502.
16. McDonald C, Allen J, Roy A, et al. One million and counting: bacterial screening of platelet components by NHSBT, is it an effective risk reduction measure? Vox Sang 2015;109:61.
17. Delage G, Bernier F, Beaudoin J, et al. Improved bacterial culture of platelet product: preliminary results after implementation of a two-bottle system with 48-hour sampling. Transfusion 2016;56:28A.
18. Wagner S, Eder A. A model to predict the improvement of automated blood culture detection by doubling platelet sample volume. Transfusion 2007;47:430-;3.
19. Eder A, Kennedy J, Dy B, et al. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009;49:1554-;63.
20. Jenkins C, Ramírez-Arcos S, Goldman M, et al. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011;51:2555-;65.
21. Bruhn R, Custer B, Vanderpool S, et al. Impact of increasing sample volume from 4 mL to 8 mL on bacterial detection rates in apheresis platelets: a meta-analysis. Vox Sang 2015;108:318-;20.
22. Murphy W, Foley M, Doherty C, et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-;9.
23. Pearce S, Rowe G, Field S. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011;21:25-;32.
24. Annual SHOT report [Internet]. Manchester: SHOT Office; 2015 [cited 2017 Mar 17]. Available from: https://www.shotuk.org/wp-content/uploads/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked-1.pdf.